Nexium Control (esomeprazole)
- Region
- 🇪🇺 EU
- Active substance
- esomeprazole
- Company
- Haleon Ireland Dungarvan Limited
- Status
- Authorised
- Therapeutic area
- Gastroesophageal Reflux
- CHMP opinion
- Thu 27 Jun 2013
- EU approval
- Mon 26 Aug 2013
- Application
- EMEA/H/C/002618
- ATC
- A02BC05
- Official record
- www.ema.europa.eu
Indication
Nexium Control is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults.
Regulatory milestones
No milestones recorded in the last year.
Follow Nexium Control
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.